Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MAXCYTE, INC. | 600,000 | reported | 27 Mar 2026 | tx 21+2,269,500−150,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Mar 2026 | GRANT_AWARD | MAXCYTE, INC. | 300,000 | 0.00 USD | |
| 27 Mar 2026 | GRANT_AWARD | MAXCYTE, INC. | 600,000 | 0.00 USD | deriv |
| 13 Aug 2025 | PURCHASE | MAXCYTE, INC. | 75,000 | 1.37 USD | first after silence |
| 14 Mar 2025 | GRANT_AWARD | MAXCYTE, INC. | 347,500 | 0.00 USD | deriv |
| 07 Jun 2024 | PURCHASE | MAXCYTE, INC. | 29,557 | 4.87 USD | |
| 10 Jun 2024 | PURCHASE | MAXCYTE, INC. | 70,443 | 4.90 USD | |
| 03 Jan 2024 | GRANT_AWARD | MAXCYTE, INC. | 400,000 | 0.00 USD | deriv |
| 20 Mar 2023 | GRANT_AWARD | MAXCYTE, INC. | 120,000 | 0.00 USD | deriv |
| 25 Mar 2022 | GRANT_AWARD | MAXCYTE, INC. | 242,000 | 0.00 USD | deriv |
| 12 Nov 2021 | EXERCISE | MAXCYTE, INC. | 25,722 | 2.08 USD | |
| 12 Nov 2021 | SALE | MAXCYTE, INC. | 25,722 | 12.66 USD | |
| 15 Nov 2021 | EXERCISE | MAXCYTE, INC. | 24,278 | 2.08 USD | |
| 15 Nov 2021 | EXERCISE | MAXCYTE, INC. | 6,438 | 3.25 USD | |
| 15 Nov 2021 | SALE | MAXCYTE, INC. | 30,716 | 12.16 USD | |
| 16 Nov 2021 | EXERCISE | MAXCYTE, INC. | 18,562 | 3.25 USD | |
| 16 Nov 2021 | SALE | MAXCYTE, INC. | 18,562 | 12.08 USD | |
| 16 Nov 2021 | EXERCISE | MAXCYTE, INC. | 18,562 | 0.00 USD | deriv |
| 12 Nov 2021 | EXERCISE | MAXCYTE, INC. | 25,722 | 0.00 USD | deriv |
| 15 Nov 2021 | EXERCISE | MAXCYTE, INC. | 24,278 | 0.00 USD | deriv |
| 15 Nov 2021 | EXERCISE | MAXCYTE, INC. | 6,438 | 0.00 USD | deriv |
| 09 Aug 2021 | GRANT_AWARD | MAXCYTE, INC. | 10,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 13 Aug 2025.